Charts & Graphs
Insiders' Section 16 Filings
Drive, Suite 9
Fort Myers, FL
FREE E-MAIL ALERTS
NeoGenomics, Inc. - Additional Information
September 2014 NeoGenomics Investor Presentation and Company Overview
September 2014 Investor Presentation by NeoGenomics, (Nasdaq: NEO) a fast growing cancer genetic testing lab traded on Nasdaq.
Investment Profile for NeoGenomics, Cancer Genetics Diagnostic Testing Lab. Listed on Nasdaq: Symbol NEO
Investment Profile for NeoGenomics, Cancer Genetics Diagnostic Testing Lab, Listed on Nasdaq: NEO
NeoGenomics Q2 2014 Earnings Conference Call Webcast
The Company held a conference call to discuss their Q2 2014 results on July 17, 2014.
The web-cast may be accessed under the Investor Relations section of the NeoGenomics website at
. An archive of the web-cast will be available until 11:59 PM on October 17, 2014.
©2014 Hawk Associates, Inc.